333 related articles for article (PubMed ID: 24774301)
1. Good guy or bad guy: the opposing roles of microRNA 125b in cancer.
Banzhaf-Strathmann J; Edbauer D
Cell Commun Signal; 2014 Apr; 12():30. PubMed ID: 24774301
[TBL] [Abstract][Full Text] [Related]
2. miR-125b acts as a tumor suppressor in breast tumorigenesis via its novel direct targets ENPEP, CK2-α, CCNJ, and MEGF9.
Feliciano A; Castellvi J; Artero-Castro A; Leal JA; Romagosa C; Hernández-Losa J; Peg V; Fabra A; Vidal F; Kondoh H; Ramón Y Cajal S; Lleonart ME
PLoS One; 2013; 8(10):e76247. PubMed ID: 24098452
[TBL] [Abstract][Full Text] [Related]
3. Regulation of placenta growth factor by microRNA-125b in hepatocellular cancer.
Alpini G; Glaser SS; Zhang JP; Francis H; Han Y; Gong J; Stokes A; Francis T; Hughart N; Hubble L; Zhuang SM; Meng F
J Hepatol; 2011 Dec; 55(6):1339-45. PubMed ID: 21703189
[TBL] [Abstract][Full Text] [Related]
4. Essential functions of miR-125b in cancer.
Peng B; Theng PY; Le MTN
Cell Prolif; 2021 Feb; 54(2):e12913. PubMed ID: 33332677
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-125b down-regulation mediates endometrial cancer invasion by targeting ERBB2.
Shang C; Lu YM; Meng LR
Med Sci Monit; 2012 Apr; 18(4):BR149-55. PubMed ID: 22460089
[TBL] [Abstract][Full Text] [Related]
6. Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway.
Nakanishi H; Taccioli C; Palatini J; Fernandez-Cymering C; Cui R; Kim T; Volinia S; Croce CM
Oncogene; 2014 Feb; 33(6):702-12. PubMed ID: 23416980
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4.
Zhou JN; Zeng Q; Wang HY; Zhang B; Li ST; Nan X; Cao N; Fu CJ; Yan XL; Jia YL; Wang JX; Zhao AH; Li ZW; Li YH; Xie XY; Zhang XM; Dong Y; Xu YC; He LJ; Yue W; Pei XT
Hepatology; 2015 Sep; 62(3):801-15. PubMed ID: 25953743
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-125b down-regulates matrix metallopeptidase 13 and inhibits cutaneous squamous cell carcinoma cell proliferation, migration, and invasion.
Xu N; Zhang L; Meisgen F; Harada M; Heilborn J; Homey B; Grandér D; Ståhle M; Sonkoly E; Pivarcsi A
J Biol Chem; 2012 Aug; 287(35):29899-908. PubMed ID: 22782903
[TBL] [Abstract][Full Text] [Related]
9. Prognostic marker microRNA-125b inhibits tumorigenic properties of hepatocellular carcinoma cells via suppressing tumorigenic molecule eIF5A2.
Tsang FH; Au V; Lu WJ; Shek FH; Liu AM; Luk JM; Fan ST; Poon RT; Lee NP
Dig Dis Sci; 2014 Oct; 59(10):2477-87. PubMed ID: 24811246
[TBL] [Abstract][Full Text] [Related]
10. Regulation of several androgen-induced genes through the repression of the miR-99a/let-7c/miR-125b-2 miRNA cluster in prostate cancer cells.
Sun D; Layer R; Mueller AC; Cichewicz MA; Negishi M; Paschal BM; Dutta A
Oncogene; 2014 Mar; 33(11):1448-57. PubMed ID: 23503464
[TBL] [Abstract][Full Text] [Related]
11. miRNA and cancer; computational and experimental approaches.
Tutar Y
Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
[TBL] [Abstract][Full Text] [Related]
12. miR-125b suppresses oral oncogenicity by targeting the anti-oxidative gene PRXL2A.
Chen YF; Wei YY; Yang CC; Liu CJ; Yeh LY; Chou CH; Chang KW; Lin SC
Redox Biol; 2019 Apr; 22():101140. PubMed ID: 30785086
[TBL] [Abstract][Full Text] [Related]
13. Oncomir miR-125b suppresses p14(ARF) to modulate p53-dependent and p53-independent apoptosis in prostate cancer.
Amir S; Ma AH; Shi XB; Xue L; Kung HJ; Devere White RW
PLoS One; 2013; 8(4):e61064. PubMed ID: 23585871
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression.
Kappelmann M; Kuphal S; Meister G; Vardimon L; Bosserhoff AK
Oncogene; 2013 Jun; 32(24):2984-91. PubMed ID: 22797068
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-125 in immunity and cancer.
Wang JK; Wang Z; Li G
Cancer Lett; 2019 Jul; 454():134-145. PubMed ID: 30981762
[TBL] [Abstract][Full Text] [Related]
16. The expression and regulation of microRNA-125b in cancers.
Huang K; Dong S; Li W; Xie Z
Acta Biochim Biophys Sin (Shanghai); 2013 Oct; 45(10):803-5. PubMed ID: 23800395
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-125b inhibits cell proliferation and induces cell apoptosis in esophageal squamous cell carcinoma by targeting BMF.
Fan YX; Bian XH; Qian PD; Chen ZZ; Wen J; Luo YH; Yan PW; Zhang Q
Oncol Rep; 2018 Jul; 40(1):61-72. PubMed ID: 29749531
[TBL] [Abstract][Full Text] [Related]
18. MiR-125b regulates proliferation and apoptosis of nasopharyngeal carcinoma by targeting A20/NF-κB signaling pathway.
Zheng Z; Qu JQ; Yi HM; Ye X; Huang W; Xiao T; Li JY; Wang YY; Feng J; Zhu JF; Lu SS; Yi H; Xiao ZQ
Cell Death Dis; 2017 Jun; 8(6):e2855. PubMed ID: 28569771
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-125b induces metastasis by targeting STARD13 in MCF-7 and MDA-MB-231 breast cancer cells.
Tang F; Zhang R; He Y; Zou M; Guo L; Xi T
PLoS One; 2012; 7(5):e35435. PubMed ID: 22693547
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA MALAT1 promotes oral squamous cell carcinoma development via microRNA-125b/STAT3 axis.
Chang SM; Hu WW
J Cell Physiol; 2018 Apr; 233(4):3384-3396. PubMed ID: 28926115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]